Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
15,956,296
-
Share change
-
+82,392
-
Total reported value
-
$852,479,241
-
Put/Call ratio
-
78%
-
Price per share
-
$53.42
-
Number of holders
-
164
-
Value change
-
+$1,040,360
-
Number of buys
-
79
-
Number of sells
-
82
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2017
As of 31 Dec 2017,
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,956,296 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, Park West Asset Management LLC, Hudson Executive Capital LP, IRIDIAN ASSET MANAGEMENT LLC/CT, STATE STREET CORP, LSV ASSET MANAGEMENT, First Eagle Investment Management, LLC, and Vanguard Group Inc.
This page lists
164
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.